These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1823 related items for PubMed ID: 16533771

  • 21. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [Abstract] [Full Text] [Related]

  • 22. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM.
    Cancer Res; 2000 Nov 15; 60(22):6488-95. PubMed ID: 11103818
    [Abstract] [Full Text] [Related]

  • 23. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R, Kimura N, Harada Y, Ohuchi N.
    Int J Oncol; 2001 Mar 15; 18(3):513-20. PubMed ID: 11179480
    [Abstract] [Full Text] [Related]

  • 24. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
    Mareel M, Vleminckx K, Vermeulen S, Yan G, Bracke M, van Roy F.
    Princess Takamatsu Symp; 1994 Mar 15; 24():63-80. PubMed ID: 8983064
    [Abstract] [Full Text] [Related]

  • 25. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M.
    Ann Acad Med Stetin; 2006 Mar 15; 52(2):23-32. PubMed ID: 17633394
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep 15; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
    Clavel CE, Nollet F, Berx G, Tejpar S, Nawrocki-Raby B, Kaplan HH, van Roy FM, Birembaut PL.
    J Pathol; 2001 May 15; 194(1):20-6. PubMed ID: 11329137
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 34. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
    Abuetabh Y, Persad S, Nagamori S, Huggins J, Al-Bahrani R, Sergi C.
    Ann Clin Lab Sci; 2011 Aug 01; 41(3):217-23. PubMed ID: 22075503
    [Abstract] [Full Text] [Related]

  • 35. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M, Lee HK, Kang YK.
    Anticancer Res; 2003 Aug 01; 23(2B):1581-8. PubMed ID: 12820426
    [Abstract] [Full Text] [Related]

  • 36. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.
    Campo L, Turley H, Han C, Pezzella F, Gatter KC, Harris AL, Fox SB.
    J Pathol; 2005 Apr 01; 205(5):585-91. PubMed ID: 15776477
    [Abstract] [Full Text] [Related]

  • 37. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M, Savarese F, Novatchkova M, Semb H, Christofori G.
    Oncogene; 2007 Apr 05; 26(16):2290-8. PubMed ID: 17043652
    [Abstract] [Full Text] [Related]

  • 38. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T, McGlynn LM, Campbell FM, Müller S, Tovey SM, Dunne B, Nielsen KV, Cooke TG, Bartlett JM.
    Clin Cancer Res; 2007 Mar 01; 13(5):1405-11. PubMed ID: 17332282
    [Abstract] [Full Text] [Related]

  • 39. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix.
    Rodríguez-Sastre MA, González-Maya L, Delgado R, Lizano M, Tsubaki G, Mohar A, García-Carrancá A.
    Gynecol Oncol; 2005 May 01; 97(2):330-6. PubMed ID: 15863126
    [Abstract] [Full Text] [Related]

  • 40. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.
    Park SS, Kim JE, Kim YA, Kim YC, Kim SW.
    Histopathology; 2005 Dec 01; 47(6):625-30. PubMed ID: 16324201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 92.